Mark Howard is an experienced scientist specializing in clinical development and global medical affairs, focusing on cell biology and inflammation. With a strong scientific record that includes publications, patents, and a book chapter, Mark has earned national recognition as one of the top early career researchers in 2007. Currently serving as the Cross Immunology Strategy & Execution Lead at AbbVie, Mark has held various leadership roles in global medical affairs, driving strategy and execution across therapeutic areas. Mark completed their PhD in Human Anatomy and Cell Biology at the University of Liverpool in 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices